Jeffrey Drazen
12 posts
Jeffrey Drazen
@JeffDrazen
Pulmonary, Critical Care Physician, Editor, New England Journal of Medicine
Boston, MA, USA Bergabung Haziran 2009
11 Mengikuti823 Pengikut
@halegroves just received a gift from Hale Groves. One orange is rotten-brown and squishy. Been on hold for a while with no response
English
@karlachilders @EeshanKhandekar @HealthPrivacy @NASEM_Health @MichelleM_Mello In 13 day's time we look forward to a robust discussion of all facets of the data sharing issue. We want it to work-but for that to be the case, we need examples of success!
#DataSharingChat
English

@EeshanKhandekar @HealthPrivacy @NASEM_Health Yes! Love this piece by .@MichelleM_Mello and colleagues. Let's ask the participants what they actually think about #clinicaltrialdata sharing. #DataSharingChat
English

Q3: What is the value proposition for #ClinicalTrial #DataSharing? Is the juice worth the squeeze? #DataSharingChat

English
@NASEM_Health #DataSharingChat #DataSharing The best way to make data sharing something we all do is to use extant datasets to help reliably advance diagnostics or therapeutics? A few clear examples will go a long way!
English

Q5: How can institutions, funders, industry, and publishers ensure the sustainability of #ClinicalTrial #DataSharing? #DataSharingChat

English
@VivliCenter @AAMC #datasharingchat This is a major problem. If we can get the promotions committees of medical schools, to give "promotion credit" for generating public use datasets, we will have gone a long way toward making sharing more prevalent.
English

Join our webinar next week, which focuses talks by the colleagues from MRCT and @aamc on providing credit for data generators--a key incentive that is needed! bit.ly/2NlbgWA #ClinicalTrial #datasharingchat #datasharingchat
English
@karlachilders @NASEM_Health It is the problem of causal inference that makes data reuse difficult. What methods have you used to overcome this issue? #DataSharingchat
English

@NASEM_Health We've seen lots of interesting questions answered through data sharing! We further our understanding of disease, expand the base of knowledge to generate new insights and more complete evidence to enable better healthcare decisions for patients. @NASEM_Health #DataSharingChat
English
@NASEM_Health #DataSharingchat What we have learned is that there are very few successful third party use cases of trial data-but we know from other fields that opening data enhances the science. We are still waiting for clinical trial data sharing to yield huge benefits.
English

Q2: What are lessons learned based on implementation of #ClinicalTrial #DataSharing and re-use policies? #DataSharingChat

English
@NASEM_Health In less than a fortnight's time our workshop on data sharing will be in full swing #DataSharingChat . How do we serve all three constituencies-the patients who put themselves at risk, the clinical trialists, and the data scientists to advance human health?
English

Welcome to the #DataSharingChat! We’d like to hear your thoughts on potential ways that stakeholders can consider the value of data sharing. Follow along with us at @NASEM_Health using #DataSharingChat! Who’s joining us today?

English
This is Jeff Drazen-one of the co-chairs of the conference. We have an exciting program all set to roll in less than 2 weeks. What's on your mind in advance of the program?
NASEM Health@NASEM_Health
Welcome to the #DataSharingChat! We’d like to hear your thoughts on potential ways that stakeholders can consider the value of data sharing. Follow along with us at @NASEM_Health using #DataSharingChat! Who’s joining us today?
English
We have just posted this video about how medical care has really improved in the past 200 years!
nejm200.nejm.org/explore/medica… #NEJM
English